Cargando…
Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis
Human papillomavirus (HPV) infection drives tumorigenesis in almost all cervical cancers and a fraction of vulvar and penile cancers. Due to increasing incidence and low vaccination rates, many will still have to face HPV-related morbidity and mortality in the upcoming years. Current treatment optio...
Autores principales: | Rafael, Tynisha S., Rotman, Jossie, Brouwer, Oscar R., van der Poel, Henk G., Mom, Constantijne H., Kenter, Gemma G., de Gruijl, Tanja D., Jordanova, Ekaterina S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876514/ https://www.ncbi.nlm.nih.gov/pubmed/35207374 http://dx.doi.org/10.3390/jcm11041101 |
Ejemplares similares
-
HPV16 variants distribution in invasive cancers of the cervix, vulva, vagina, penis, and anus
por: Nicolás‐Párraga, Sara, et al.
Publicado: (2016) -
‘DURVIT’: a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment
por: Rotman, J., et al.
Publicado: (2018) -
Unlocking the therapeutic potential of primary tumor-draining lymph nodes
por: Rotman, Jossie, et al.
Publicado: (2019) -
Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix
por: Heeren, A Marijne, et al.
Publicado: (2016) -
Double Penis and Double Vulva
por: MacLennan, Alex.
Publicado: (1924)